Literature DB >> 2086166

Pharmacokinetics of terlipressin after single i.v. doses to healthy volunteers.

G Nilsson1, P Lindblom, M Ohlin, R Berling, E Vernersson.   

Abstract

The pharmacokinetics of triglycyl-lysine-vasopressin (TGLVP) were studied in healthy male volunteers after single i.v. injections of 5, 10 and 20 micrograms/kg b. wt. The half-life of distribution and elimination was 8 and 50 min, respectively. The volume of distribution was 0.7 l/kg b.wt. and the plasma clearance 9 ml/kg b.wt./min. These values are different from those for arginine-vasopressin and lysine-vasopressin (LVP) but confirm to some extent earlier results on TGLVP. No dose-dependent changes of the pharmacokinetics of TGLVP were evident. The LVP formation after TGLVP is described in principle using a combination of pharmacokinetic and pharmacodynamic data. Therapeutically the results in this study suggest a 4-hour interval between injections.

Mesh:

Substances:

Year:  1990        PMID: 2086166

Source DB:  PubMed          Journal:  Drugs Exp Clin Res        ISSN: 0378-6501


  13 in total

1.  Effects of two different dosing regimens of terlipressin on organ functions in ovine endotoxemia.

Authors:  Matthias Lange; Christian Ertmer; Sebastian Rehberg; Andrea Morelli; Gabriele Köhler; Tim G Kampmeier; Hugo Van Aken; Martin Westphal
Journal:  Inflamm Res       Date:  2010-12-29       Impact factor: 4.575

Review 2.  Recent advances in our understanding of hepatorenal syndrome.

Authors:  Florence Wong
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-22       Impact factor: 46.802

3.  Current place of vasopressin analogues in the treatment of septic shock.

Authors:  Christian Ertmer; Sebastian Rehberg; Andrea Morelli; Martin Westphal
Journal:  Curr Infect Dis Rep       Date:  2008-09       Impact factor: 3.725

Review 4.  Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis.

Authors:  Matthias Lange; Christian Ertmer; Martin Westphal
Journal:  Intensive Care Med       Date:  2007-12-08       Impact factor: 17.440

Review 5.  [New therapeutic approaches in the treatment of shock: hypertonic hyperoncotic solutions and vasopressin].

Authors:  A Meier-Hellman; G Burgard
Journal:  Internist (Berl)       Date:  2004-03       Impact factor: 0.743

Review 6.  Modulation of splanchnic circulation: Role in perioperative management of liver transplant patients.

Authors:  Ahmed Mukhtar; Hany Dabbous
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

7.  The effects of terlipressin on regional hemodynamics and kidney function in experimental hyperdynamic sepsis.

Authors:  Ken Ishikawa; Li Wan; Paolo Calzavacca; Rinaldo Bellomo; Michael Bailey; Clive N May
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

Review 8.  Bench-to-bedside review: Vasopressin in the management of septic shock.

Authors:  James A Russell
Journal:  Crit Care       Date:  2011-08-11       Impact factor: 9.097

9.  Vasopressin vs Terlipressin in Treatment of Refractory Shock.

Authors:  G Scarpati; O Piazza
Journal:  Transl Med UniSa       Date:  2013-01-04

10.  Using terlipressin in a pediatric patient with septic shock resistant to catecholamines.

Authors:  Seher Erdogan; Mehmet Bosnak
Journal:  North Clin Istanb       Date:  2017-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.